# Society Pass Incorporated.: overview SOPAQ · OTC · CIK 1817511 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/sopaq.md) · [Financials](/companies/sopaq/financials.md) · [Filings](/companies/sopaq/filings.md) · [Insiders](/companies/sopaq/insiders.md) Latest reported revenue: [$1.4m](/filings/0001493152-25-022564.md) for Q3 FY2025, three months to 2025-09-30, from the 10-Q filed Nov 14, 2025 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001493152-25-022564). ## Last eight quarters | Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [1.7 d](/filings/0001213900-25-032266.md) | [1.8](/filings/0001213900-25-045955.md) | [1.7](/filings/0001641172-25-023454.md) | [1.7](/filings/0001493152-25-022564.md) | [1.9 d](/filings/0001213900-25-032266.md) | [1.5](/filings/0001213900-25-045955.md) | [2.5](/filings/0001641172-25-023454.md) | [1.4](/filings/0001493152-25-022564.md) | | Gross margin | % | [38.5% d](/filings/0001213900-25-032266.md) | [26.7%](/filings/0001213900-25-045955.md) | [27.1%](/filings/0001641172-25-023454.md) | [21.8%](/filings/0001493152-25-022564.md) | [28.9% d](/filings/0001213900-25-032266.md) | [31.6%](/filings/0001213900-25-045955.md) | [56.5%](/filings/0001641172-25-023454.md) | [64.3%](/filings/0001493152-25-022564.md) | | Operating margin | % | [(296.0%) d](/filings/0001213900-25-032266.md) | [(156.6%)](/filings/0001213900-25-045955.md) | [(126.0%)](/filings/0001641172-25-023454.md) | [(70.1%)](/filings/0001493152-25-022564.md) | [(165.6%) d](/filings/0001213900-25-032266.md) | [(126.6%)](/filings/0001213900-25-045955.md) | [(6.1%)](/filings/0001641172-25-023454.md) | [(379.9%)](/filings/0001493152-25-022564.md) | | Net margin | % | [(338.5%) d](/filings/0001213900-25-032266.md) | [(153.8%)](/filings/0001213900-25-045955.md) | [(113.3%)](/filings/0001641172-25-023454.md) | [(82.2%)](/filings/0001493152-25-022564.md) | [(217.5%) d](/filings/0001213900-25-032266.md) | [(124.9%)](/filings/0001213900-25-045955.md) | [19.1%](/filings/0001641172-25-023454.md) | [(370.8%)](/filings/0001493152-25-022564.md) | | Diluted EPS | $ per share | not reported | [(1.21)](/filings/0001213900-25-045955.md) | [(0.73)](/filings/0001641172-25-023454.md) | [(0.48)](/filings/0001493152-25-022564.md) | not reported | [(0.44)](/filings/0001213900-25-045955.md) | [0.10](/filings/0001641172-25-023454.md) | [(0.89)](/filings/0001493152-25-022564.md) | | Free cash flow | $m | [(4.1) d](/filings/0001213900-25-032266.md) | not reported | not reported | not reported | [3.6 d](/filings/0001213900-25-032266.md) | not reported | not reported | [(16.7) d](/filings/0001493152-25-022564.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure. ## Last five fiscal years | Line item | Unit | FY (2020-12-31) | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [0.1](/filings/0001607062-22-000218.md) | [0.5](/filings/0001607062-23-000144.md) | [5.6](/filings/0001213900-24-032944.md) | [8.2](/filings/0001213900-25-032266.md) | [7.1](/filings/0001213900-25-032266.md) | | Gross margin | % | [(69.0%)](/filings/0001607062-22-000218.md) | [(36.7%)](/filings/0001607062-23-000144.md) | [17.2%](/filings/0001213900-24-032944.md) | [30.2%](/filings/0001213900-25-032266.md) | [26.2%](/filings/0001213900-25-032266.md) | | Operating margin | % | [(7149.7%)](/filings/0001607062-22-000218.md) | [(6580.7%)](/filings/0001607062-23-000144.md) | [(606.1%)](/filings/0001213900-24-032944.md) | [(219.8%)](/filings/0001213900-25-032266.md) | [(131.2%)](/filings/0001213900-25-032266.md) | | Net margin | % | [(7297.9%)](/filings/0001607062-22-000218.md) | [(6706.2%)](/filings/0001607062-23-000144.md) | [(599.5%)](/filings/0001213900-24-032944.md) | [(221.9%)](/filings/0001213900-25-032266.md) | [(143.9%)](/filings/0001213900-25-032266.md) | | Diluted EPS | $ per share | [(0.56)](/filings/0001607062-22-000218.md) | [(3.68)](/filings/0001607062-23-000144.md) | [(1.38)](/filings/0001213900-24-032944.md) | [(9.39)](/filings/0001213900-25-032266.md) | [(3.45)](/filings/0001213900-25-032266.md) | | Free cash flow | $m | not reported | [(10.9)](/filings/0001607062-23-000144.md) | [(15.0)](/filings/0001213900-24-032944.md) | [(14.1)](/filings/0001213900-25-032266.md) | [2.4](/filings/0001213900-25-032266.md) | - Revenue. XBRL Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/sopaq/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) None of the funds in coverage reports a position in its latest 13F. ## Recent filings [All 227 filings](/companies/sopaq/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-09-30 | 16:00 ET | [8-K/A](/filings/0001493152-26-045096.md) | 5.02 Departure or appointment of officers or directors | 0001493152-26-045096 | | 2026-09-29 | 16:00 ET | [8-K](/filings/0001493152-26-044860.md) | 5.02 Departure or appointment of officers or directors | 0001493152-26-044860 | | 2026-06-08 | 12:05 ET | [8-K](/filings/0001493152-26-027671.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001493152-26-027671 | | 2026-05-20 | 06:05 ET | [8-K](/filings/0001493152-26-024495.md) | 3.01 Delisting notice | 0001493152-26-024495 | | 2026-05-14 | 17:00 ET | [8-K](/filings/0001493152-26-023162.md) | 1.03 Bankruptcy or receivership; 2.04 Item not in the standard list; 8.01 Other events | 0001493152-26-023162 | | 2026-04-21 | 17:20 ET | [8-K](/filings/0001493152-26-018364.md) | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001493152-26-018364 | | 2026-04-15 | 16:15 ET | [8-K](/filings/0001493152-26-016817.md) | 8.01 Other events | 0001493152-26-016817 | | 2026-03-27 | 16:20 ET | [8-K](/filings/0001493152-26-013207.md) | 3.01 Delisting notice | 0001493152-26-013207 | | 2026-02-13 | 16:00 ET | [8-K](/filings/0001493152-26-006687.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-006687 | | 2026-02-06 | 17:26 ET | [S-1/A](/filings/0001493152-26-005638.md) | Registration statement, amended | 0001493152-26-005638 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2024](/filings/0001213900-25-032266.md), filed Apr 16, 2025. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 1817511 - Tickers: SOPAQ - Exchange: OTC - SIC code: 7389 Services-Business Services, NEC - State of incorporation: NV - Filer category:
Emerging growth company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.